Multiple Vitamins Injection
Cachexia
Dartmouth-Hitchcock Medical CenterSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Cachexia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Anamorelin Helsinn Therapeutics (U.S.), Inc | Phase 3 | BB |
Ponsegromab Pfizer | Phase 2/3 | BB |
MEGESTROL ACETATE IMPURITY B Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 3 | BB |
Nanocrystalline Megestrol Acetate Suspension Nanfang Hospital, Southern Medical University | Phase 3 | BB |
Infliximab Centocor, Inc. | Phase 3 | BB |
View all 29 →
Same molecule, other indications
Multiple Vitamins Injection is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →